Summary: Radioiodinated R-and S-Quinuclidinyl deriv atives of RS-benzilate (R-and S-1 2 5IQNB) have been syn thesized for quantitative evaluation of muscarinic acetyl choline receptor binding in vivo. Two sets of experiments were performed in rats. The first involved determining the metabolite-corrected blood concentration and tissue distribution of tracer R-IQNB (active enantiomer) and S IQNB (inactive enantiomer) in brain 1 min to 26 h after intravenous injection. The second involved the measure ment of brain tissue washout over a 2-min period after loading the brain by an intracarotid artery injection of the ligands. Various pharmacokinetic models were tested, which included transport across the blood-brain barrier (BBB), nonspecific binding, low-affinity binding, and high-affinity binding. Our analysis demonstrated that the assumptions of rapid equilibrium across the BBB and rapid nonspecific binding are incorrect and result in erro neous estimates of the forward rate constant for binding at the high-affinity receptor sites (k3). The estimated val ues for influx across the BBB (K1), the steady-state ac cumulation rate in cerebrum (K), and the dissociation rate constant at the high-affinity site (k4) of R-IQNB were in dependent of the specific compartmental model used to analyze these data (K1 = 0.23 mllmin/g, K = 0.13 mil min/g, and k4 = 0.0019 min -I for caudate). In contrast, the estimated values of k3 and the efflux rate constant (k 2 ) 
varied over a 10-fold range between different compart mental models (k3 = 2.3-22 min -I and k2 = 1.6-16 min-I in caudate), but their ratios were constant (k31k2 = 1.4). Our analysis demonstrates that the estimates of k3 (and derived values such as the binding potential) are model dependent, that the rate of R-IQNB accumulation in ce rebrum depends on transport across the BBB as well as the rate of binding, and that uptake in cerebrum is essen tially irreversible during the first 360 min after intrave nous administration. Graphical analysis was consistent with compartmental analysis of the data and indicated that steady-state uptake of R-IQNB in cerebrum is estab lished within 1-5 min after intravenous injection. We pro pose a new approach to the analysis of R-IQNB time activity data that yields reliable quantitative estimates of k3, k4, and the nonspecific binding equilibrium constant (Keq) by either compartmental or graphical analysis. The approach is based on determining the free unbound frac tion of radiolabeled ligand in blood and an estimate of K1• The analysis can be applied to time-activity data obtained in a clinical setting using either positron emission tomog raphy or single photon emission computed tomography and has general application for other highly lipophilic ligands. Key Words: Blood-brain barrier-Muscarinic acetylcholine receptor binding-Quinuclidinyl benzilate.
Muscarinic acetylcholine receptor (m-AChR) binding has been identified biochemically in vitro by the binding of cholinergic agonists (Farrow and O ' Brien, 1973; Schleifer and Eldefrawi , 1974) and antagonists (Yamamura and Snyder, 1974 ; Yama mura et aI., 1974a,b) . 3-Quinuclidinyl benzilate (QNB) is a potent muscarinic antagonist (Albanus, 1970; Meyerhoffer, 1972) . Using eH]QNB, Yama mura and co-workers identified selective in vitro binding to muscarinic cholinergic receptor sites in mammalian brain (Yamamura and Snyder, 1974; Yamamura et aI ., 1974a) . Yamamura et aI . (1974b) also reported the accumulation of eH]QNB by var ious regions of rat brain in a fashion that indicates that QNB selectively labels the muscarinic cholin ergic receptor in vivo. The relative amounts of QNB binding in the regions of brain that were ex amined paralleled the relative number of m-AChR sites determined by an in vitro [ 3 H]QNB binding study (Yamamura and Snyder, 1974 ; Yamamura et aI., 1974a) and by neurophysiologic investigations (McLennan and York, 1966) . However, a pharma cokinetic analysis of in vivo tissue activity-time data for the estimation of QNB receptor binding parameters has not been performed previously.
Recently, Rzeszotarski et aI . (1984) prepared a radioiodinated ligand {1 2 5I-labeled R-l -aza-bicyclo (2.2. 2)oct -3-yl-R, S-a-hydroxy-( 4-[ 1 2 5I]iodopheny 1) phenyl acetate (R_1 2 5IQNB)}. Gibson et al . (1984a) showed that R_1 2 5IQNB exhibits an affinity for the m-AChRs from corpus striatum that is slightly higher than that of eH]QNB in vivo. Using single photon emission imaging techniques, high levels of radioactivity (R_1 2 3 IQNB) were detected in the ce rebrum but not in the cerebellum of human subjects (Eckelman et aI ., 1984) , and this approach has been used in the study of Alzheimer ' s disease (Holman et aI ., 1985) .
In this study, we measured the blood concentra tion and tissue activity-time profile of tracer R-1 2 5IQNB and the inactive enantiomer S_1 2 5IQNB in various regions of rat brain after intravenous admin istration. We also measured the washout of both R and S-IQNB from the same regions of rat brain after intracarotid artery administration. These two data sets were analyzed by various compartmental mod els that incorporated transport across the blood brain barrier (BBB), nonspecific binding in the tis sue, as well as low-affinity and high-affinity binding to the muscarinic receptor. The issues raised in this article focus on (a) '1 comparison between compart mental analysis and graphical analysis (Patlak and Blasberg, 1985) and (b) the development of a new approach to the analysis of in vivo receptor-ligand binding time-activity data that has potential appli-J Cereb Blood Flow Metab, Vol. 10, No.6, 1990 cation using positron emission tomography (PET) or single proton emission computed tomography (SPECT). 
MATERIALS AND METHODS

Chemicals
Synthesis of isotopically labeled compounds
Based on the synthesis previously described (Rzeszo tarski et aI ., 1982 (Rzeszo tarski et aI ., , 1984 , the triazene derivative of QNB (R-or S-enantiomer as appropriate) was reacted with [1251] _ or [131l] sodium iodide to produce one of the desired p-iodinated products: R_125IQNB, S_12 5IQNB, or S-131IQNB. The radioligands were purified by HPLC using two 25-cm Lichrosorb C-18 reverse phase columns in se ries and eluted with a mobile phase consisting of 5 mM octane sulfonic acid in 60:40 MeOH/H 2 0 (pH 3.5) with formic acid at a flow rate of 1 mVmin at ambient temper ature . The fraction containing the product (90 ml) was collected and rotary evaporated to dryness, aqueous NaHC0 3 was added, and the fraction was extracted with ethyl acetate, rotary evaporated to dryness, and stored in 95% ethanol until used. The elution volume of the radio ligand was the same as that for an authentic sample of IQNB and exhibits the same Rf values on silica gel as the authentic sample in two TLC systems: 20% MeOH/ CHCl 3 (Rf = 0.4) and butanoVacetic acid/water 4: 1: 1 (Rf = 0.46). The final R_125IQNB product had specific activ ities of >500 Cilmmol.
The isomeric composition of the synthesized IQNB was determined by the in vitro kinetics of dissociation from receptors derived from the corpus striatum. The in troduction of iodine into the phenyl ring introduces a sec ond chiral center (Gibson et aI ., 1989) . Although the tri azene was prepared with R-( -)-quinuclidinol (>99%), the benzilate moiety was 80% R-iodophenyl-a-hy droxy-a-phenylacetate. The small component of the S isomer of the benzilate moiety was not evident in the kinetic analysis of the in vivo studies. The dominant di astereomer obtained with the R-( -)quinuclidinol is R,R IQNB and is referred to as R-IQNB. S-IQNB was syn thesized using S-( + )-quinuclidinol and S-benzilate.
Animal experiments
Male Sprague-Dawley rats, weighing 250-350 g, were obtained from Taconic Farms (Germantown, NY, U.S.A.). Two sets of experiments were performed: (a) intraarterial-brain uptake and washout over 2 min after intracarotid artery injection; and (b) intravenous-brain uptake and washout over 26 h after intravenous injection. For the intraarterial experiments, rats were anesthetized with pentobarbital (45 mg/kg i.p.) and a polyethylene catheter was inserted in the trachea to maintain stable breathing. The vessels of the right side of the neck were exposed. A 50-IJ.I bolus of whole blood, containing 2 f.LCi of R_125IQNB, 2 IJ.Ci of S_131IQNB, and 0.5-1 .0 IJ.Ci of 4 6Sc-microspheres (-100,000 spheres) was rapidly in jected via a 27-gauge needle into the carotid artery (Old endorf, 1970) . Animals were decapitated at 0.084, 0.25, 0.5, 1, 1.5, and 2 min after injection.
For the intravenous experiments, animals were in jected with 20 IJ.Ci of R_125IQNB or S-125IQNB via the tail vein (2-to 26-hr long-duration experiments) or via a fem oral vein catheter (1-to 60-min short-duration experi ments). Tail vein injection and femoral vessel catheter ization (PE-50 polyethylene tubing, one vein and two ar teries) were performed under gas anesthesia (halothane/ nitrous oxide/oxygen 1.5 :30:70 vol/vol/vol). The long duration experimental animals were returned to their cages, rapidly recovered from anesthesia, and were al lowed free access to water and food. They were decapi tated at the appropriate time (2, 4, 6, 12, 18, 24 , and 26 h) ; cervical blood was immediately obtained after decapita tion and various tissues were sampled. Whole-blood, plasma, and tissue radioactivity was measured. The short-duration experimental animals were partially re strained in plaster casts and allowed to recover from an esthesia for at least 1 h before the experiment; physiolog ical parameters were monitored and body temperature was maintained at 36-3rC with heat lamps. Arterial blood (100 1J.l) was sampled during the experiments (0.25, 0.5, 0.75, 1, 1.5, 2, 3, 5, 10, 15, 20, 30, 45 , and 60 min); whole-blood and plasma radioactivity was measured. The animals were decapitated at the end of the experiment (1, 5, 15, 30, and 60 min) and various tissues were sampled. The mean hematocrits at the end of these experiments were 40.5, 42. 1, 41.6, 40.0, and 39.8, respectively. Autoradiography S_125IQNB or R_125IQNB (0.5, 0.75, or 1.0 mCi) was injected intravenously. Animals were decapitated at 2, 6, 12, and 24 h for the S_125IQNB experiments and at 0.5, 1, 2, 6, 12, and 24 h for the R_125IQNB experiments. Sec tions of brain tissue were prepared for autoradiography as previously described (Blasberg et aI ., 198 1) . Serial sec tions were cut 20 IJ.m thick at -20°C in a cryomicrotome at intervals of 600 IJ.m, placed on glass coverslips or mi croscope slides, and dried rapidly on a slide warmer at 65°C. The dried tissue sections were placed in a cassette along with 17 fre shly prepared liver homogenate 1251 _ labeled standards (1.4-21,742 nCi/g) and single-coated x ray film (SB-5; Kodak, Rochester, NY, U.S.A.) for a 10-to 6O-day period of exposure.
IQNB metabolism
Brain tissue and plasma samples were obtained at var ious times after intravenous injection of R-and S-1251QNB (autoradiographic series of experiments) ; each sample was homogenized in phosphate buffer (0.1 M, pH 8.0) (buffer/sample ratio 3: 1) and extracted in an equal volume of ethyl acetate (by vortex and centrifugation). Radioactivity in the organic and aqueous fractions was measured. The ethyl acetate fraction was evaporated (N 2 gas at room temperature) to near dryness and pipetted on silica gel plates for TLC ; the aqueous fraction was di rectly plated for TLC. The TLC plates were developed in chloroform/methanol (80:20, vol/vol) and analyzed on a Bioscan System 200 imaging scanner.
Binding of R-and S_ 125 IQNB to plasma protein and red cells
All the procedures were carried out immediately after blood collection. Plasma protein binding was determined by an ultrafiltration method using a Centricon (Amicon, Danvers, MA, U.S.A.), which provides 10% of the initial plasma volume after centrifugation at 1,000 g for 15 min. Plasma samples (0.5 ml) containing 0.5 IJ.Ci of R-or S-1251QNB were applied to the membrane after incubation at 37°C for 10 min. The free (unbound) fraction in plasma (fp) was calculated from (1) where Cp and Cu are the measured concentrations in plasma and ultrafiltrate, respectively. The adsorption of these compounds to the membrane was negligible. For binding of ligands to red cells, the blood was incubated with 1 IJ.Ci of R-or S_125IQNB at 37°C for 10 min. The plasma and blood concentration of the ligands and the hematocrit were determined. Hemolysis during the incu bation was negligible. Red cell/plasma concentration ra tios (Cre/Cp) were calculated by the following equation:
where Cp, Cre' and Cb are the plasma, red cell, He and blood concentrations of 1251QNB, respectively, and He is the hematocrit determined by centrifugation. The free (unbound) fraction in blood (fb) was calculated by where Wb is the water content of blood; for the rat, Wb = 0.82 ml water/ml blood (Altman, 196 1) . Equation 3 as sumes equal concentrations of 1251QNB in red cell and plasma water at equilibrium.
Calculations
The extraction ratio [E(t)] was calculated by (4) where CT(t) and CR(t) have units of percentage dose per gram tissue of the test compound (R_12 5IQNB or S-l 3 l IQNB) and the reference compound ( 4 6Sc-micro spheres), respectively. The extraction of microspheres in the brain has been shown to be constant over time and was taken to be 1 at all times after injection. E(t) repre sents the maximal extraction of unidirectional influx into brain minus the component of back-diffusion at time t after injection. The maximal extraction [E(O)] was esti mated by extrapolation of the washout curves to 4 s after injection to account for the time required for bolus entry into brain capillaries (Sawada et aI ., 1989) . The E(t)/E(O) ratio represents the relative extraction of the test sub stance at time t. The value of E(O) could also be used to calculate influx constant (K 1 ) for all models by
where F is blood flow (mUmin/g) in the brain region of interest.
Metabolite-corrected concentrations of IQNB in blood (Cb ; % dose/g blood) were obtained according to the fol lowing equation: Cb = C;pp . R� . Rbp (6) where C;pp is a percentage of dose per gram plasma based on measured radioactivity, R� is the parent fraction at each sampling time (see Fig. 4 ), and Rbp is the blood/ plasma concentration ratio (Cb/Cp) of the parent com pound based on in vitro measurements (see Table 2 ) . The brain tissue amount (% of dose/g tissue ; AT) corrected for metabolite and intravascular activity was obtained by the fo llowing equation: (7) where A�pp, C�pp' and C:�p are the apparent percentage of dose per gram brain, plasma, and red cells based on mea sured radioactivity, respectively; and R� is the vascular space-corrected parent fraction in the tissue at each time (see Table 3 ); and V p (0.0105 mUg in cortex, 0.016 ml/g in cerebellum, 0.0045 mUg in caudate putamen, and 0.0050 mUg in thalamus) and Vrc (0.0057 mUg in cortex, 0.0086 mUg in cerebellum, 0.0026 mUg in caudate putamen, and 0.0042 mUg in thalamus) are the plasma and red cell vol umes in brain, respectively (Blasberg et ai. , 19 83) . 
Cb
Model development
The challenge of receptor mapping in vivo is not only to provide evidence of receptor-specific accumulation of a specific radioligand in vivo, but also to yield quantitative estimates of specific features of the binding sites, such as their number and affinity. However, the in vivo distribu tion of a radioligand is likely to be influenced by a variety of factors in addition to the number of receptors and their affinity. These include binding to nonspecific sites, BBB permeability, and blood flow . In this analysis, we inves tigated the effects of these factors on the estimation of receptor binding parameters.
Two different sets of experiments were performed: (a) brain washout following intracarotid artery injection of the ligands and (b) brain uptake and retention following intravenous injection. The data from both experimental sets were combined and analyzed simultaneously using various pharmacokinetic models of ligand distribution and nonlinear least-squares fitting of the data. The differ ential equations and solutions for the analysis are shown in Appendix A.
It should be noted that the blood clearance or influx constant (K1) and the dissociation rate constant from the high-affinity receptor (k 4 ) are common parameters and have the same meaning for all models in Fig. 1 . In con trast, the interpretation of the efflux rate constant (k 2 ) and the association rate constant for the high-affinity receptor (k) will be different for different models since they are influenced by other parameters in the models (e.g., ks and k6 and/or k� and k�) .
Models for S-IQNB distribution in all brain regions
Mo dels for S-IQNB distribution in cerebellum, frontal cortex, parietal cortex, caudate putamen, and thalamus are shown in Fig. lA 
Models for R-IQNB distribution in cerebellum
Mo dels for R-IQNB distribution in cerebellum are shown in Fig. lB (ks, k6 ; these values were assumed to be identical to those obtained for S-IQNB using Model 2), and the other site represents low-affinity specific binding (k;, k�).
Data analysis using Model 5 is similar to that using Model 4, except for the constraint imposed by including ks and k6; in both models the nonlinear least-squares fit of the data results in estimates of four unknown parameters (K 1 , k2, k�, k�). We excluded the possibility of more complex models or fitting more than four unknowns (two exponential fit) owing to the paucity and scatter of the experimental data points and to the large estimated errors associated with the fits of higher-order equations. The rate constants k2 and k3 are not equivalent between mod els (see below) .
Models for R-IQNB distribution in cerebrum
Models for R-IQNB distribution in frontal cortex, pa rietal cortex, caudate putamen, and thalamus are shown in Fig. Ie. In each case , the values of K1, k2' k3, and k4 were determined by nonlinear least-squares analysis. As noted above, we excluded more complex models or fitting more than four unknowns.
Model 6 is mathematically identical to Models 2 and 4 and assumes one high-affinity binding site (k3, k4); non specific binding and/or low-affinity binding and disso ciation are assumed to be either instantaneous and in corporated into k2 or sufficiently slow and kinetically indistinguishable from k3 and k4• Models 7 and 8 are math ematically similar to Model 5; two independent binding sites are assumed. In Model 7 the low-affinity site (k;, k�) was assumed to be identical to that described for cere bellum (Model 4) and the rate constants for the high affi nity site (k3, k4) were determined. Similarly, in Model 8 nonspecific binding and dissociation (ks, k6) were as sumed to be identical to those determined for S-IQNB in each brain structure (Model 2) and the rate constants for the high-affi nity site (k3, k4) were determined. Model 9 as sumes three independent binding sites; nonspecific binding and dissociation (ks, k6) were assumed to be iden tical to those determined for S-IQ N B in each brain structure (Model 2), a low-affinity site (k;, k�) was assumed to be identical to that described for cerebellum (Model 5), and the rate constants for the high-affinity site (k3, k4)
were determined. The difference in the analysis of the data between Model 6 and Models 7-9 is the constraint imposed on the least-squares fit by including ks and k6 (Models 8 and 9) and k; and k� (Models 7 and 9). The rate constants k2 and k3 in Models 6 through 9 are not equivalent; in the steady state they are related by
and
where superscripts m6 and mj refer to Model 6 and the jth model (Models 7-9; Fig. 1 ) and BPj is the binding poten tial (Appendix B; Mintun et al ., 1984) of the ith compart ment. Thus,
RESULTS
Solubility and binding to blood elements
The solubility of IQNB in octanol/water, ethyl acetate/saline, and ethyl acetate/plasma is shown in Table 1 . The extraction of IQNB in octanol and ethyl acetate was pH dependent (Fig. 2) . The effect of pH on the lipid-aqueous partitioning of IQNB cannot be explained solely by the pKa of the quinu clidine moiety (pKa = 10.95).
The plasma unbound fraction and the binding to red blood cells of IQNB are shown in Table 2 . IQNB binds strongly to blood constituents and there was no significant difference between R-and S-IQNB .
Metabolism of IQNB
The fraction of radioactivity representing parent IQNB in brain tissue and plasma samples at various times after intravenous injection was determined. A single peak representing the parent compound (R or S-IQNB) was observed in the organic phase of the brain tissue samples on TLC and no parent IQNB was observed in the aqueous phase (Fig. 3A) . Table 3 shows the measured and vascular space corrected percentage radioactivity in brain tissue. Radiolabeled metabolites of R-and S-IQNB in brain tissue were negligible «5%) throughout the study. For the ethyl acetate extracts of plasma, two radi olabeled metabolites more polar than IQNB were found and they appeared to increase over the length of the experiment (Fig. 3B ). These two metabolites remain unidentified but never exceeded 40% of the total ethyl acetate radioactivity . Figure 4 shows the fraction representing R-and S-IQNB in plasma ver sus time ; the parent fraction decreased rapidly over the first 4 h. Because the fraction of IQNB in plasma at 12, 18, 24, and 26 h was so low, it was calculated as a fraction of the measured radioactiv ity in cerebellum (after correction for intravascular radioactivity ; see Eq. 7). The ratio of nonvascular cerebellum radioactivity to plasma radioactivity corrected for the parent compound (R-IQNB) reached a steady state by 6 h.
Brain washout: intraarterial experiments
The washout profiles of R_1 2 5IQNB, S-l 3 l IQNB, and 4 6 Sc-microspheres from brain after intracarotid artery injection are shown in Fig. 5 . Microspheres were trapped in the brain and remained at a con stant level during the 0-to 2-min experimental pe riod. The relationship between the E(t)IE(O) ratio and time is shown in Fig. 6 . Both isomers of IQNB demonstrated rapid efflux during 0-15 s, while after 15 s a slower exponential washout was observed. There was no difference in the washout pattern dur ing the first 2 min between the two stereoisomers in any brain region.
In vivo autoradiography Autoradiographic images of S_1 2 5IQNB and R-1 2 5IQNB distribution in brain after intravenous ad ministration are shown in Figs. 7 and 8, respec tively. For S-IQNB , the earliest image (2 h) shows a uniform distribution of 1 2 51; by 6 h considerable clearance of radioactivity had occurred from the brain and the image density remained homogeneous [very-Iow-grain-density homogeneous images (not shown) were observed at 12 and 24 h] . The autora diograms obtained with R-IQNB showed a hetero geneous distribution of 1 2 51 and notable differences were observed between the 30-min and 24-h images. High activity was seen in many structures of the cerebrum (e .g., olfactory tubercle, nucleus accum bens, hippocampus, caudate putamen, amygdala, and cortex), which persisted for 24 h. In some struc tures (e.g., thalamic and septal nuclei) , R-IQNB levels were initially high, but this activity decreased more rapidly than that in other structures noted above. In contrast, R-IQNB activity in hindbrain (e.g., cerebellum and medulla) was lower than that in forebrain at 30 min and rapidly decreased with time, similar to that observed with S-IQNB.
Blood and tissue concentration profiles: intravenous experiments
The concentration-time profiles of IQNB in blood and tissue were corrected on the basis of the me tabolism data presented in Fig. 4 (plasma) and Table 3 (brain) using Eqs. 6 and 7, respectively. The cor rected blood concentration-time profile of R-and S-IQNB is shown in Fig. 9 . Blood clearance of R- IQNB was fa ster than that of S-IQNB. The cor rected blood curves were fitted to a sum of expo nentials (see Eq. AS) ; the coefficients and expo nents of the fits are given in the legend to Fig. 9 and were used for the pharmacokinetic analysis of the tissue data (see Model Development). 
FIG. 5. Brain washout profiles. Paired studies of S_1 3 110NB (t", top) and R-12sIONB (0, bottom) plus 4 6Sc-microsphere activity (e) in various brain regions after intracarotid artery injection. The ordinate is the natural log of brain radioactiv ity, expressed as the percentage of injected dose per gram brain ; the abscissa is time. Each point is the mean ± SO, n = 3-5 animals.
tration-time profiles of S-IQNB in different brain regions were similar (Fig. 10) ; S-IQNB rapidly washed out of all tissue regions and the profiles were similar to those observed in blood (Fig. 9 ) . In cerebellum, the concentration of R-IQNB ( Fig. 11 ) was higher than that of S-IQNB (Fig. 10F) ; from 0.25 to 6 h the mean R-IQNB/S-IQNB concentra tion ratio was 2.1 ± 0.5 (SD). A lower uptake and faster washout of R-IQNB were observed in thala mus compared with cortex and caudate ( Fig. 12) . By 6 h after injection the concentration of R-IQNB in cortex and caudate was 30 times greater than that of S-IQNB ; in thalamus the R-IQNB/S-IQNB concentration ratio was 15. By 24-26 h the R IQNB/S-IQNB concentration ratio was 1,200 for cortex, 950 for caudate, and 250 for thalamus.
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A. Each value is the mean ± SO.
Pharmacokinetic analysis of blood and tissue time-activity curves
S -IQNB
Tissue distribution data of S-IQNB in cerebel lum, frontal cortex, parietal cortex, caudate puta men, and thalamus were fitted to Eq. A16 for Mod els 1 and 2 (Fig. 1) . Model l describes the transport parameters (K 1, k 2 ) and assumes that nonspecific (and specific) binding is absent or occurs very rap idly (instantaneously). Model 2 assumes measur able transport and nonspecific binding (k 5 , k 6 ) ' A fit of these data is shown in Fig. 6A (Model l, broken line; Model 2, solid line) and Fig. 10 . The estimated values for these parameters are presented in Table  4 . When rapid nonspecific binding (Model 1) was assumed, the values of k 2 were lower than the esti mates obtained with Model 2; however, the total volume of distribution (VT) was similar for both models.
FIG. 7.
Autorad iographic images of S_12510NB distribution in rat brain at 2 and 6 h after intravenous injection. Three coronal planes are show n: frontal cortex, caudate putamen, and septal nucleus (A); parietal cortex, thalamus, and hip pocampus (8); cerebellum and pons (C). The distribution data of R-IQNB in cerebellum were fitted according to Eq. A16 for three plausible compartmental models ( Table 5 . The total volume of distribution (VT) is similar (5 .5-5.9 mIl mg) in all three models and is associated with a low error estimate.
R-IQNB in cerebellum
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R-IQNB in cerebrum
The distribution data of R-IQNB in regions of cerebrum (frontal and parietal cortex, caudate puta men, and thalamus) were fitted to Eq. A16 for four plausible compartmental models (Fig. 1) . A repre sentative fit of data is shown in Fig. 6B (brain wash out) and Fig. 12 (i.v.) for Model 7. Model 6 assumes measurable transport parameters and a high-affinity binding site (k3, k4); there is either no nonspecific or low-affinity binding or it occurs rapidly (instanta neously). Model 7 assumes measurable transport and high-affinity plus low-affinity binding (k;, k�) in tissues of the cerebrum that is identical to that mea sured in cerebellum (Model 4; Table 5 ) . Model 8 assumes measurable transport and high-affinity plus nonspecific binding (k5, k6) that is identical to that measured with S-IQNB (Model 2; Table 4 ) . Model 9 assumes measurable transport parameters and three tissue compartments: high-affinity binding, low- Table 4 ).
The transport parameters (K 1, k2) and high- affi nity binding constants (k3 , k4) were estimated for each model and the results are presented in Table 6 .
The values of Kl and k4 estimated by each of the models were similar in each brain structure. In contrast, values of k2 and k3 covaried over a 10-fold range between models; the k3/k2 ratio was essen tially constant for Models 6-9 in each brain region. The errors associated with the parameter estimates were comparatively low (25-45%). The errors asso ciated with the k3/k2 and k3/k4 ratios were 40-45 and 37-49%, respectively. The value of VT was similar for all models in each brain region and associated with a lower error estimate (18-30%). VT for R IQNB was high (>200 mllg for cortex, 150--170 mllg for caudate putamen, and 50--60 mllg for thalamus) in comparison with that measured for S-IQNB in the same structures (VT = 1.5-2.3 ml/g; Table 4 ) .
DISCUSSION
The ability to image neuroreceptors with radiola beled ligands and PET or SPECT in animal and hu man brain raises the possibility that receptor den sity and affinity can be measured using the appro priate experimental protocol and mathematical model to analyze the data (Wagner et aI ., 1983 ; Burns et aI ., 1984; Mintun et aI ., 1984; Wong et aI ., 1984 Wong et aI ., , 1986 Farde et aI ., 1985 ; Frey et aI., 1985; Samson et aI ., 1985 ; Perlmutter et aI ., 1986) . How ever, the validity of different pharmacokinetic mod els that include brain uptake, nonspecific binding, as well as specific receptor binding processes has not been fu lly investigated. a Total volume of distribution (Eq. B7).
• Akaike information criterion (Eq. A29).
9.55'
e Residual weighted sum of squares (Eq. A30). We will focus on five aspects of in vivo receptor ligand binding studies. The first focuses on S-and R-IQNB transport across the BBB. The second is a comparison of several plausible compartmental models that describe specific binding of radiola beled IQNB to receptor-rich regions of the rat brain. The models include rate constants for trans- vivo estimates of R-IQNB binding parameters to the m-AChR with those obtained by in vitro studies (Gibson et aI ., 1984a) . The third fo cuses on a com parison of the compartmental and graphical analytic approaches to data analysis. The fourth part of the discussion will present a physiologically based ap proach for estimating the apparent distribution vol ume (Vf) and concentration (CfT) of unbound (free) radioligand in brain tissue and brain tissue water, respectively. The fifth part of the discussion will present a new approach for determining the rate constants of ligand binding to a specific receptor system in vivo. This approach was developed with the criterion that it must be applicable to clinical studies using either PET or SPECT techniques. This analysis of the time-activity data is based on knowing the equilibrium distribution volume of the free (unbound) ligand in the tissue relative to the total concentration of ligand (bound and unbound) in blood or plasma, local tissue blood flow (mea sured independently in a previous or consecutive study) , and an estimate of the permeability-surface area product (PSe) of the blood vessels with respect to the ligand .
Transport of IQNB across the BBB
The accurate determination of the transport pa rameters (K I ' k2) of a lipophilic ligand such as IQNB using curve-fitting techniques depends on the num ber of measured points during the period immedi ately after injection. It may be unreliable to esti mate rapid trans capillary flux from in vivo blood and tissue activity-time curves when the initial ex perimental data are obtained at times of ;;,: 1 min after injection (see later discussion). Therefore , we combined our data from both intravenous and in traarterial experiments whenever possible ; a total of 8-17 experimental time points were used to esti mate two to four parameters (see Tables 4-6 ) . Val ues of K I (0.36, 0.38 mllmin/g) and k2 (4.0, 4.8 min -I ) for R-and S-IQNB , respectively, were also obtained fr om very short experiments (0-7 s) using the indicator diffusion method and a distributed model based on capillary heterogeneity in brain (Sawada et aI., 1990) . These values for whole brain (cerebrum) were similar to those obtained for vari ous brain structures with Models 2, 5, and 7 (Sawada et aI ., 1990) indicate that influx of IQNB across brain capillaries is not completely blood flow dependent. Similarly, the ex traction of IQNB in anesthetized primates was found to be 0.56 (Gibson et aI ., 1984b) . Another important consideration for IQNB movement across the BBB and cell membranes is shown in Fig. 2 . The pH partition coefficient pro files of IQNB were sigmoidal and the slopes of the profiles were very steep within a narrow range of pH between 6.0 and 7.0. Thus, the fraction of free IQNB in blood that is ionized will likely increase in the presence of metabolic acidosis and result in a decrease in the transport rate constants across the BBB. Therefore , it is important to measure blood pH prior to and during studies with IQNB , partic ularly in certain disease states.
Binding of S-IQNB in brain tissue
S-IQNB is a stereoisomer with 100-fold lower af finity for the muscarinic Mr-receptor than the R isomer and can be used as a reference compound for nonspecific binding to cerebellum and cerebrum (Eckel man et aI., 1985) . In this study, we compared two models of S-IQNB distribution in brain tissue: Model 1 assumes rapid (instantaneous) nonspecific binding and equilibration, whereas Model 2 as sumes that the nonspecific binding constants (k5, k6) are sufficiently slow that they are measurable.
The selection criteria for choosing Model 2 over Model l to describe the distribution of S-IQNB in brain is based on a comparison of the residual weighted sum of squares and Akaike information criterion values (Table 4 ) and the plots of normal ized residuals, which demonstrate a consistent trend for Model 1 but not for Model 2 (Fig. 13) . Furthermore, the brain washout studies are incon sistent with the single-exponential clearance of S IQNB from the tissue that is predicted by Model 1 (Fig. 6A) .
S-IQNB distributes fairly uniformly throughout the brain (Fig. 7) 14) . These values may indicate that nonspecific binding of IQNB in brain is sub stantial and that it may vary over a two-to threefold range between various structures. Alternatively, S IQNB has a low but measurable affinity for the muscarinic receptor, which can produce receptor mediated localization: The rank order of k51k6 val ues for the tissues examined in this study corre spond to the relative concentrations of m-AChRs in these structures (Cortes and Palacios, 1986) and supports this latter hypothesis.
Binding of R-IQNB in cerebellum
Since the cerebellum is devoid of specific dopa minergic binding sites, binding parameters in cere bellum are used to estimate nonspecific binding of dopaminergic ligands (Wagner et aI ., 1983; Wong et aI ., 1984 Wong et aI ., , 1986 Mintun et aI., 1984; Perlmutter et aI ., 1986) . In this study , accumulation of R-IQNB in cerebellum (VT = 5.5 ml/g) was significantly higher than that of S-IQNB (VT = 1.7 ml/g) , consistent with the presence of specific R-IQNB binding sites in cerebellum (Model 5). The binding potential of R-IQNB to a low-affinity receptor in cerebellum (k;lk� = 50, Model 5) is 3.6 times greater than the nonspecific binding potential measured with S IQNB (k51k6 = 14, Model 2) .
The fitted curves resulted in lower Akaike infor mation criterion and residual weighted sum of squares values for Model 4 compared with Models 3 and 5 (Table 5 ), but the plots of normalized residu als (Fig. 14) did not reveal specific trends for any of the models. However, it may not be possible to distinguish between slow and rapid binding on the basis of the intravenous studies alone (see later dis cussion). Brain washout studies from cerebellum could not be performed to address the question of slow versus rapid binding, owing to variable vascu lar flow patterns to the cerebellum in intraarterial experiments (H. Otsuki et aI., unpublished obser vations).
Our suggestion that Model 5 (or Model 4) is most appropriate to describe R-IQNB uptake and distri bution in cerebellum is based on our analysis of all the in vivo data [indicator diffusion (Sawada et al., 1990 ) , brain washout and intravenous administra tion experiments] plus published in vitro studies. For example, Wamsley et aI. (1984) and Gibson et 0.6 Model 1 (Table 7 ). In addition, the muscarinic receptor in the cerebellum is of a different subtype than that in the corpus striatum. Luthin and Wolfe (1984) com-
Model 4 B. co 0.4 Samples 1-8 are sequential points from the intravenous ex periments.
pared [ 3 H]QNB and eH]pirenzepine (an M 1
-selec tive antagonist) in rat cerebellum and reported spe cific binding for eH]QNB, whereas there is no specific binding of eH]pirenzepine. These observa tions were confirmed qualitatively by the in vitro autoradiographic study by Mash and Potter (1985) . Gibson et a1 . (1984a) have also shown that the dis sociation kinetics of R_1 2 5IQNB from the receptor in cerebellum is 15 times more rapid than that from the receptor in the corpus striatum, although the association rate constant and equilibrium affinity constant were similar in the two brain regions. A similar difference in the rapidity of dissociation of R_1 2 5IQNB from its receptor was observed in vivo between cerebellum and caudate nucleus (as well as cortex) ; k� in cerebellum ( Table 5 ) was 18-30 times higher compared with k4 in caudate and cortex (Ta ble 6) . These observations suggest that rat cerebel lum contains some m-AChRs (predominantly of the M 2 or rapidly dissociating subclass), resulting in some specific binding of R-IQNB within this struc ture in vivo.
Binding of R-IQNB in cortex, caudate, and thalamus
The marked differences in R-IQNB concentration measured in various brain structures after intrave nous administration presumably reflect differences in binding to m-AChRs (Figs. 8, 11 , and 12). The muscarinic receptor concentration in various struc tures of the brain has been determined in several studies using in vitro autoradiographic techniques as well as tissue homogenates. The values vary widely in different brain structures; the rank order of muscarinic receptor concentration measured in vitro (Table 7) corresponds to the rank order of the binding potential of R-IQNB measured in vivo (k 3 / k4) for comparable structures (Tables 5 and 6) .
We have modeled a single high-affinity receptor system defined by the rate constants k3 and k4 in our analysis of the R-IQNB data. The assumption of a single high-affinity receptor is probably valid for caudate nucleus and cortex, but may be an over simplification for thalamus [i.e., the thalamus is re ported to exhibit 4Ck>0% of a rapidly dissociating subtype of muscarinic receptor, whereas the corpus striatum and cortex exhibit <5% of this subtype (R. E. Gibson, unpublished data)] . The pattern of "rapid" dissociation from the receptor and loss of R_1 2 5IQNB from certain structures of the brain ob served in vivo (Fig. 8) corresponds closely to the structures that are low in the M l and high in the M 2 subclass of receptor as defined qualitatively by Mash and Potter (1985) in their in vitro autoradio- graphic study. Similarly , those structures that re tain high levels of R-1 2 5IQNB radioactivity at 12 and 24 h and have a "slow" rate of dissociation from the receptor (Fig. 8) correspond to structures that are high in the MJ and comparatively low in the M 2 subclass of muscarinic receptor defined by Mash and Potter (1985) .
Four plausible pharmacokinetic models were compared in our analysis ( Table 6 ) . On the basis of Akaike information and residual weighted sum of squares criteria (Table 6 ) and a plot of normalized residuals (Fig. 15) , the four models are similar with respect to fitting the 17 experimental data points. Thus, curve fitting alone cannot discriminate be tween the four models. These observations present an apparent dilemma: The value and interpretation of the forward binding rate constant for IQNB bind-
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• ing to the muscarinic receptor (k3) depend on the particular model used to analyze the data; similarly for any parameters derived from k3 ' such as the binding potential (k3Ik4 ; Eq. B4) or the kon . B:nax product (Eq. Bl). In contrast, the estimated values of the dissociation rate constant (k4) and the total volume of distribution (VT) were essentially model independent ( Table 6) .
KJ was essentially the same for all analyses (Mod els 6--9; Table 6 ) ; this would be expected since KIKJ = k3/(k2 + k3) (see subsequent discussion of graph ical analysis; Eq. C2) . We have also shown that k3 and k2 covary such that k31k2 is essentially constant in each brain region for Models 6--9 (Table 6) . Thus, the KJ • k31k2 product is also a constant (model independent) value and equivalent to kon . B:naxlV 2 (Eq. Bl), where Vd in Eq. Bl is the physical volume of distribution of the ligand in the system being studied. Knowing the distribution volume of the un bound free ligand in the tissue (Vf) could resolve the apparent dilemma with respect to the "true" value of k3 for in vivo experiments.
Comparison between compartmental analysis and graphical analysis
An alternative method to analyze tissue and blood concentration-time data was proposed by Patlak et al . (1983) when one or more processes in the system involved irreversible trapping or bind ing. Recently, the method of graphical analysis was expanded to include the capability to analyze sys tems in which a slowly reversible component of the trapping or binding process occurs (Patlak and Blas berg, 1985) . One of the advantages of graphical analysis is that the resultant information is indepen dent of the actual configuration of the compartmen tal system being analyzed. A second advantage is that it predicts a time (t*) when all reversible tissue compartments have reached approximate steady state with the blood. At time t* the graphical plot becomes linear (Fig. 16) and no further information about the system can be obtained by compartmental analysis. Therefore , we have compared conven tional compartmental analysis and graphical analy- 7 and 6, respectively, where Am is equivalent to AT) and plot ted against f� Cb(T)dT/Cb(t) (Patlak et aI., 1983) or f� e-kb(t -Tj Cb(T)dT/Cb(t) (Eq. C1) (Patlak and Blasberg , 1985) , where Cb is equ ivalent to Ca' The ordinate has units of distribution volume (ml/g); the abscissa has units of time (min), which has been described as "stretch time" or "normalized time," In (A) the data from 1-to 360-min experiments result in a linear relationship. In (8) the abscissa is expanded to include the 1,560-min experiments and the line fitted in A is extended; the later experimental points fall progressively below the ex tended line, indicating that R-IONB uptake is not completely irreversible. In (e), the data are corrected to account for a slow rate of loss from the tissue (kb)' The fitted values of the slope (K) and kb' based on a weighted least-squares regres sion, are given in Table 8 .
sis of the R-IQNB data obtained from the intrave nous set of experiments; the appropriate equations are given in Appendix C. Graphical analysis of R-IQNB uptake in cortex and caudate yielded a linear plot for experiments between I and 360 min (Fig. 16A) ; for thalamus, the plot was linear for 1-to 120-min experiments. Dur ing these periods, R-IQNB uptake in the tissue was essentially irreversible. Expanding the ab scissa scale through 1,560-min experiments revealed a curvature in the plot of the data that reflects a slow loss of R-IQNB from the tissue. Presumably, this loss is due to dissociation of R-IQNB from the high affinity muscarinic receptor, the site of "irreversible" binding (Fig. 16B) . We have attempted to distinguish between rapidly and slowly dissociating muscarinic receptor subtypes in different structures of cerebrum. As discussed above, this approach is probably justifiable for caudate nucleus and cortex but may be an oversimplification for thalamus. The rate constant for R-IQNB loss from the tissue (kb) can be estimated by graphical analysis (Fig. 16C) , provided that it is small in relation to other eigen values of the system (Patlak and Blasberg, 1985) . In this study kb has been related to the dissociation rate constant of the high-affi nity receptor (k4) for all the compartment models (Models 6-9) using Eq. C3 .
The steady-state uptake rate constant (K; slope of the linear portion of the graphical plot), the tissue loss constant (kb) , and t * for R-IQNB in various brain regions determined by graphical analysis are compared with corresponding values calculated from the rate constants determined by conventional compartmental analysis in Table 8 . The fitted and calculated values of K and kb compare favorably. The transient period t * was estimated to be -1-5 min from the graphical plots and is consistent with the rate constants k 2 ' k� , and k 6 determined by compartmental analysis. Thus, the rate of R-IQNB accumulation in cerebrum reaches a steady state rapidly, and information concerning the transient phase (e .g., transport across the BBB, nonspecific or low-affi nity binding, etc.) must be obtained from short-duration experiments (e.g., indicator diffu sion and brain washout experiments). The corollary to this conclusion is that experimental data obtained 1-5 min after intravenous injection cannot yield ac curate estimates of K\ and k 2 (as well as nonspecific or low-affinity binding rate constants) for highly li pophilic ligands such as IQNB.
Graphical analysis does not provide a direct esti mate of the association (k 3 ) or dissociation (k4) rate constants (Patlak and Blasberg, 1985) . When k 2 > > k 3' Eq. C3 reduces to kb = k 4 and K = Vr · k 3 (Eq. C2), where Vr = K\/k 2 . This condition is unlikely for most nellroreceptor ligands since the association of R-IQNB with the muscarinic receptor is very rapid in vitro (Gibson et aI ., 1984a) . The opposite condi tion, where k 3 > > k 2 ' has been suggested for very high-affinity receptor-ligand interactions. If k 3 > > k 2 ' Eq. C2 reduces to K = K\, the slope of the graphical plot is a measure of ligand transport (P S and/or F), and kb becomes much smaller than k4 (Eq. C3). However, for our compartmental analysis of R-IQNB uptake in rat cerebrum, k 3 = k 2 (Table 6 ) and the steady-state uptake rate is dependent on both transport and binding to a high-affi nity recep tor. hBased on data from 1-to 1,560-min experiments; kb > 0 was assumed . , Based on data from 1-to 360-min experiments ; kb = 0 was assumed. j Based on data from 1-to l20-min experiments ; kb = 0 was assumed.
Apparent distribution volume and concentration of unbound (free) ligand in brain
The large difference between the measured influx and efflux constants, expressed as a low K/k 2 ratio, may be due to substantial binding of IQNB to intra vascular plasma protein and red cells as has been shown for other drugs (Pardridge et aI ., 1983) . Blas berg et ai . (1988, 1989) have adopted the classical hypothesis that there is little or no binding of radio ligands such as IQNB in extracellular space fluid of brain (owing to the absence of plasma proteins and red cells) and that the concentration of radio ligand in brain extracellular fluid equals the concentration of free unbound radioligand in plasma (blood) water at equilibrium. Experimental support for this pro posal is given by the correspondence between CSF and plasma ultrafiltrate concentrations of S-IQNB under equilibrium conditions (R. Kawai et aI ., un published observations). Furthermore , Dubey et ai. (1989) have recently shown, using microdialysis probes, that the free unbound concentrations of an other lipophilic radioligand eHldiazepam, are equal in blood and brain extracellular fluid under equilib rium conditions.
Assuming that free unbound IQNB distributes passively between extracellular and intracellular water, the concentration of unbound ligand in the tissue relative to the concentration of IQNB in blood at equilibrium can be expressed as an appar ent volume of distribution of unbound free drug (Vf) : where Crr and Cfb are the unbound (free) concen trations of IQNB in brain tissue water and blood and Cbb is the bound concentration of IQNB in blood; WT represents the water content of brain tis sue, equal to 0.79 ml water/g rat cerebrum (Grome et aI ., 1988) . At equilibrium ( 12) and using Eq. 3 (13) where Wb represents the water content of blood (0.82 ml water/ml blood; Altman, 1961) and 'A.w is the tissuelblood water partition coefficient ('A.w = W T /Wb = 0.96 ml blood/g brain) . The nonequilibrium state between blood and tissue can be analyzed with compartmental analysis by assuming (a) rapidly (in stantaneously) reversible drug binding to blood el ements or (b) no dissociation of drug from blood elements during passage through the capillaries.
Since the extraction ratio (Eo) of IQNB (Sawada et aI ., 1990 ;  see also legend to Fig. 6 ) is substantially larger than the free fraction in blood ifb ; Table 2 ), we have assumed that the first condition applies to IQNB in our kinetic analysis (Sawada et aI ., 1990) .
If we define the K,/k 2 ratio in terms of Vf, then this ratio can be determined from independent mea surements of fb and �w:
where k 2 is the dependent variable. Since fb is 0.059--0 .060, Vf is estimated to be �0.057 mllg under these assumptions. This value is similar to the K/k 2 ratios calculated for S-IQNB (0. 042-0.11 mllg, Model 2; Table 4 ) and for R-IQNB (0. 048-0.117 mll g, Models 5 and 7; Tables 5 and 6) in five different brain regions. The similarity between the estimated K,/k 2 ratio for these models, the PS,/k2 ratio from indicator diffusion experiments (Sawada et aI ., 1990) , the CSF/plasma concentration ratio at equi librium (R. Kawai et aI., unpublished observations), and the free fraction of IQNB measured in blood if b . �w) is consistent with passive flux of free un bound IQNB across the capillaries.
Equations 12 and 13 state that the "free" un bound concentration of ligand in tissue water de pends onfb and the concentration of ligand in blood and that additional ligand in the tissue can be con sidered to be bound (e.g., nonspecific reversible binding and/or binding to specific receptor sites). The advantage of this formulation is that it permits an estimate of the "free" ligand concentration in tissue water at equilibrium: (15) and can be very useful in the analysis of time activity data in brain of highly lipophilic ligands such as IQNB. Furthermore, Vf is the appropriate value for Vd in Eq. Bl for equilibrium experiments in vivo. For nonequilibrium experiments , Vf and eft will vary ; for the steady-state uptake phase of a ligand such as R-IQNB or spiroperidol (Gjedde et aI ., 1986), Vf = K,/(k 2 + k 3 ) ' Thus, Vf will have a direct effect on the estimates of the kon • B�ax prod uct (Eq. Bl) and the dissociation constant (Kd) from experimental data obtained in vivo in which there is significant binding of the ligand to blood elements.
For most in vitro experiments, Vd (or Vf) is as sumed to be unity (mllm!) ; however, Vd was also assumed to be unity or equivalent to the tissue wa ter space (mllcc) for recent in vivo studies (Frey et aI ., 1985 ; Wong et aI., 1986) . In contrast, we have suggested that Vf (and therefore Vd) can be deter mined from independent measurements offb and �w (Eq. 13) and that this value can be used in the analysis of experimental in vivo data. By "fixing" the K,/k 2 ratio on the basis of Vf (Eq. 14), reliable and physiologically based estimates of k 3 can be ob tained (Blasberg et aI ., 1988 (Blasberg et aI ., , 1989 .
Frost et ai . (1989) also recognized that the K/k 2 ratio could be "fixed" in the analysis of their data and used this approach in a study of opiate recep tors in human subjects with ["C]carfentanil and PET. However, their estimate of the K/k 2 ratio was based on a two-compartment model and four parameter fit of the e 'C]carfentanil time-activity data in occipital cortex, a region assumed to be de void of opiate receptors . Their estimates of the K,/ k 2 ratio for ["C]carfentanil in five subjects ranged between 0.24 and 0.83 mllml without naloxone and between 0. 15 and 0.65 mllml with naloxone pre treatment. This three-to fourfold range in K,/k 2 is not likely to reflect physiological variation in the apparent distribution volume of [" C]carfentanil in the "extracellular" compartment of their model, but rather reflects the inherent variation in the fit of the data from different subjects. "Fixing" the K/k 2 ratio on the basis of fb �w as we propose here (Eq. 14) is conceptually quite different. It is based on an independent measure of the free fraction of parent radioligand in blood water and an assumption that is physiologically tenable and indirectly supported by the experimental data noted above.
Potential clinical applications
Since IQNB has high affinity to muscarinic M, receptors and is essentially irreversibly bound in cortex and caudate during the first 360 min after intravenous injection, it may have potential for im aging muscarinic receptors in human brain using SPECT (Eckelman et aI., 1984) . The analysis of SPECT data may be facilitated by comparing the ratio of cerebral and cerebellar time-activity mea surements; therefore, we tested the validity of this approach by applying graphical analysis to our data in the rat (Patlak and Blasberg, 1985) . Two different brain regions were compared as shown in Fig. 17 , a muscarinic receptor-rich region such as cortex or caudate and a receptor-poor region such as cerebel lum, knowing that the criterion for choosing a brain region devoid of muscarinic receptors and specific binding was not strictly met by selecting the cere bellum (Patlak and Blasberg, 1985) . However, the concentration of muscarinic receptors in the cere bellum has been shown to be small with respect to that in cortex and caudate in vitro (Table 7) , and we have shown that the specific binding potential (k 3 / k 4 ; Eq. B4) of R-IQNB in cortex and caudate is 45-69 times greater than that in cerebellum in vivo (Models 5 and 7; Tables 5 and 6) . [Am(T)IA�(T)l was calculated from corrected cerebrum and cerebellum radioactivity measurements (Eq. 7), respectively, and plotted against f� e-kb(t -TI Am(T)dTIA;"(t) (Eq. C5) (Patlak and Blasberg , 1985) , where Am is equivalent to AT' The ordi nate is dimensionless (distribution ratio); the abscissa has units of time (min), which has been described as "stretch time" or "normalized time." The fitted values of the slope K+ [KI(V� + V�)l and k�. based on a weighted least-squares re gression, are given in Table 8 .
We compared the values of k� (Eq. C5) and kb (Eq. C1) with the values calculated from the rate constants (Model 7; Table 6 ; Eq. C3), and the val ues of V� (Eq. C7) with Ve (Eq. C4) in data with respect to determining the desired kinetic parameters can be resolved in one of several ways .
We have shown that the efflux rate constant (k2) of IQNB is high and have suggested that the efflux of unbound IQNB from brain is blood flow dependent (Sawada et al., 1990) . Under these conditions the transport parameters (K I ' k2) of a highly lipophilic ligand such as IQNB can be calculated from a knowledge of regional blood flow, the effective per meability-surface area product, and the ratio of the unbound or free concentration in brain to total blood concentration at equilibrium (V6 Eq. 11) . Both F and Vf (Eq. 13) can be obtained from inde pendent measurements. In addition, an estimate of the permeability-surface area product of the un bound ligand in blood (PSe) can be obtained from a relationship proposed by Fenstermacher (1983 Fenstermacher ( , 1989 :
where PC is the octanol/water partition coefficient and Dm is the aqueous diffusion constant [propor tional to (molecular weight)lh] of the ligand at 37°C.
The effective or apparent P S (PS I ) can be calcu lated from PSI = PSe . fb (Sawada et al ., 1990) , and K 1 can be calculated from a modification of the Crone (1963 )-Renkin (1959 relationship that was developed for a single capillary:
If PS I and/or F cannot be estimated or deter mined independently, it may be possible to estimate K I fr om the initial phase of the tissue and blood time-activity profile before steady-state uptake is reached. The duration of this initial uptake period during which useful data can be obtained to estab lish the transport parameters (and rapidly equili brating nonspecific binding parameters) of a recep tor binding ligand from the time-activity profile is t < t * , where t * is defined by graphical analysis (Pat lak et al., 1983) . For an intravenous bolus injection of R-IQNB in conscious rats, t * is 1-5 min. An ac curate determination of K I from the initial phase of the tissue-blood activity profile may be possible with PET, particularly if a short intravenous infu sion is used to administer the radioligand. How ever, this approach is not likely to be possible with SPECT, particularly for lipophilic ligands that rap idly cross the BBB and rapidly achieve a steady state of "free" ligand between tissue and blood.
Knowing K I , k2 can be defined as KI/Vf and ob tained from K 1 /ifb . l\w) (Eq. 14). Then, estimates of the desired binding parameters (namely, k 3 and k4) can be obtained from the tissue and blood time activity data using compartmental or graphical anal ysis. This approach establishes a defined and phys iologically based relationship between the concen tration of ligand measured in blood and the "free concentration" of ligand in tissue water (presum ably at the receptor site) and reduces the number of parameters to be estimated by one. A compartmen tal analysis of the intravenous data using this ap proach was performed on the 30-to I,S60-min data to simulate the conditions of SPECT; the results are shown in Table 9 . Similarly, graphical analysis can be used to estimate k3 from the slope (K; Eq. C1): (18) provided Vr and KJ are known. For the case where two brain regions are compared by graphical anal ysis as described above and the equilibrium con stant for rapidly reversible (nonspecific) binding (Keq) is known or calculated (Eq. C8) or Keq < < 1, k3 can be calculated from
where K+ is the slope of the plot (Eq. C6) and k2 is obtained from K/Vr (Eq. 14). Knowing k3 , k4 can be calculated from the estimate of kb obtained by graphical analysis and from k2 (Eq. C3). These cal culations were performed and the results are shown in Table 9 .
Nonspecific tissue binding can contribute signif icantly to total tissue radioactivity . In our analysis of the 30-to 1 ,S60-min experimental data presented in Table 9 , nonspecific tissue binding was assumed to be in steady state with blood and the equilibrium constant for nonspecific tissue binding (Keq) was evaluated in three ways. First, Keq was estimated fr om the R-IQNB time-activity data for each brain structure (Table 9 , compartmental analysis, three parameter fit, bold type). Second, Keq was calcu lated from the S-IQNB data obtained in each struc ture (Model 2; Table 4) , since S-IQNB has very low affinity for muscarinic receptors (Eckel man et al ., 1985) . Using the S-IQNB-determined values of Keq and the same approach as described above, the re ceptor association and dissociation rate constants (k3 , k4) were estimated by a two-parameter fit of the tracer R-IQNB data (Table 9 , compartmental anal ysis, normal type). Third, Keq was estimated from graphical analysis of the R-IQNB data using a ratio of slopes K and K+ , and Vr (Table 8 ; Eq. C8). In all three analyses, Keq was small in comparison with the receptor binding potential k3/k4 of tracer R IQNB.
A comparison of the results from four different analyses (two compartmental and two graphical) in Table 9 shows a consistency of the desired receptor binding parameters for R-IQNB in four brain re gions. The largest differences were between the es timates of Keq and Ve obtained from compartmental analysis. The fitted values of KJ (Table 6) differ from the derived values of K J (Table 9) calculated from the estimated PS and values of blood flow measured in comparable animals by a factor of three to four. This difference may be due to the presence of un stirred water layers or noninstanta neous equilibration between "free" and "bound" IQNB in the vascular compartment during capillary transit. Most important, there were no large differ ences between the values of k3 ' k4 ' k3/k4' and VT estimated from the different analyses of the data.
Thus, we suggest that reliable estimates of k3' k4 '
and Keq can be obtained from experimental time activity data of R-IQNB (and other lipophilic recep tor ligands) provided Vr is known and an estimate of KJ can be obtained.
Errors could be propagated in the estimates of k3 ' k3/k4' and Keq from errors in the calculated or esti mated value of KJ and from errors in the determi nation of fb for the analysis shown in Table 9 . The values of k3 ' k3/k4' and Keq covary with k2' and k2 is fixed in relation to KJ in our analysis by Vr ifb . Aw;
Eq. 14). Although our analysis has the possibility to propagate errors, a major advantage is obtained by establishing a physiological basis for the apparent distribution volume (Vr; Eq. 13) and the concentra tion of free ligand in tissue water (Crr ; Eq. IS). If Crr is the concentration of ligand at the receptor site , a physiological basis for estimating receptor ligand binding parameters from time-activity data is also obtained. These points are similar in concept to that proposed and used by Mintun et al . (1984) . We suggest that this combined approach to time activity data analysis shown in Table 9 provides for wider application, particularly with SPECT, and far outweighs its limitations.
CONCLUSIONS
To determine the binding parameters of R-IQNB to high-affi nity m-AChRs in vivo, we developed several plausible pharmacokinetic models that de scribe transport , nonspecific binding, and specific binding in brain. Our analysis demonstrates that in travenous experiments longer than I-S min in the rat cannot provide information from which accurate estimates of blood-brain transport and nonspecific e Calculated values based on K, K' and kb , kb (Table 8) .
f Free fraction in plasma (Table 2) ; free fraction in blood if b ) was calculated from Eq. 3.
g Estimated from log PSe = 5.2 + log (partition coefficient · diffusion constant) (Sawada et ai ., 1990) .
h Blood flow from Kawai et ai. (1 988) . i Calculated by Eq. 13.
j Calculated from PSc . Ib (Sawada et ai ., 1990) . k Calculated from F( I -ePSJIF) .
I Calculated from K I !Vr.
m Calculated from VI I + Keq) .
n Calculated from VI I + Keq + kik4) . G Bold script; calculated from slope K (Eq . 18); normal script: calculated from slope K+ (Eq . 19 ). P Calculated from kb (bold) or kb (normal) (Eq . C3).
q Calculated from Eq . C8. o Calculated from K!K + (Eq . C7 ).
binding of IQNB can be obtained and that the dif ferent models yield different estimates of the for ward rate constant for high-affinity binding (k3). In contrast, the dissociation rate constant for high affi nity binding (k4) and the total volume of distri bution of the ligand (VT) were estimated with a high degree of confidence and were similar for different pharmacokinetic models and thus independent of the specific compartmental system. Our analysis of the rate constants suggests that R-IQNB accumula tion in cerebrum is dependent on transport across the BBB as well as the rate of binding. The trans port limitation of influx of the highly lipophilic IQNB ligand reflects the high degree of plasma pro tein and red cell binding (Sawada et aI. , 1989 dA e "dt = KICa -k 2 Ae -kJAe + k¢b -ksAe
The blood curve was fitted to a sum of exponentials
where m is the number of exponentials.
A formal solution of the equations can be obtained by the method of Laplace transform:
The transformed dependent variables are in bold type and Eqs. AI-A5 take the form of Eqs. A7-AlO: SAe = K1Ca -(k 2 + k3 + ks + k3) Ae
The final equation was solved numerically based on the inverse Laplace transform. Numerical inverse Laplace transform was carried out by the Hosono method (1983), based on the first inverse Laplace transform algorithm as described by Sawada et al . (1989) .
Models for intraarterial (brain washout) experiments
The brain washout experiments were performed on anesthetized animals. We shall make the assumption that the rate constants, except for KI and k2' were unaffected by the anesthesia. The differential equations in the case of the most complex model (Model 9) are as follows: The solutions were analogous to those for the intravenous experiments with [K I �7' = I B/(S + 13;)] replaced by 1.0.
Combining intraarterial (brain washout) and intravenous experiments
To obtain a single set of rate constants for anesthetized and awake animals, three assumptions were required. First (assumption l), all rate constants except KI and k2 are unaffected by the anesthesia. Second (assumption 2), the apparent K l lk 2 ratio is unaffected by the anesthesia. for a single capillary system (Renkin, 1959; Crone, 1963) and where the superscript a refers to the value in anes thetized animals. From Eq. 5 for the anesthetized animal,
and therefore
K I = F{I -[I -E'(O)f'IF} (A24)
Under assumption 3, -In ( I -� I ) = P: I
Inserting Eq. A23 into A25 and rearranging yields
From assumption 2,
where IG is calculated from Eq. A23 and KI is calculated from Eq. A24 for the case of assumption 3a and from Eq. A26 for the case of assumption 3b. The value of k2 (Eq. A28 can then be inserted into Eq. Al7. The value of Pin anesthetized animals was measured under the same con ditions as the intraarterial experiments (Otsuki et al., 1989) ; the value of F in the intravenous experiments (awake animals) was taken from Kawai et al . (1988) .
Assumption 3a, PS I unaffected by the anesthesia, was used for the analysis presented in Tables 4-6 . This as sumption is supported by the results of Pawlik et al. (198l) and Collins et al. (1987) , which indicated that >85% of all capillaries in the anesthetized cat are contin uously perfused and only 10% of rat brain capillaries are available for recruitment. Furthermore, there was little or no difference in the fraction of fu nctional capillaries be tween awake (84%) and barbiturate-anesthetized (9 1%) animals (Collins et al., 1987) , and capillary perfusion studies in hypercapnic conscious rats failed to demon strate capillary recruitment (Gobel et al ., 1989) .
Analytical method
Coefficient (B;) , exponential term ([3;), and transport (K1 , k2) and binding (k3, k4' k5' k6' k�, and k�) parameters were determined by simultaneously fitting the blood con centration and tissue activity-time curves of both the in travenous and the intraarterial experiments to the models by nonlinear least-squares regression (Hanano, 1987) .
Evaluation of models Akaike (l973a, b) proposed an information criterion (AIC) to help differentiate between various kinetic mod els that can be used to describe and fit a particular set of experimental data. Akaike (1976) and Tanabe (1975 Tanabe ( , 1976 defined the criterion by the following equations on the assumption that the random errors obey Gaussian distri bution:
where N is the number of experimental data points, P is the number of parameters in an estimated model, and SS is the residual weighted sum of squares. SS is defined as The term ka (k3 or k�) is the rate constant for the asso ciation of tracer ligand with the receptors of interest in a region, equal to the product of the bimolecular associa tion constant (kon) and the quantity of receptor sites avail able for binding (B;"'ax): (B I) where V d is the physical volume of distribution of the ligand and has previously been assumed to be unity (Frey et al ., 1985) or equivalent to the tissue water space (Wong et al ., 1986) . The term B;"'ax is used to represent unoccu pied receptors, while Bmax is the total number of recep tors, some of which may be blocked by endogenous ligands. The term kJ3 (k4 or k�) represents dissociation of ligand from receptor; when tracer amounts of ligand are used and B;"'ax remains constant during the experiment,
The binding potential (BP) (Mintun et al., 1984) The total volume of distribution in brain tissue (V T) for the models in Fig. 1 can be expressed as
where BP; is the binding potential for the ith compartment and m is the number of compartments.
APPENDIX C
The general equation for graphical analysis of tracer radioligand uptake that is only slightly reversible during the experimental period is given by where Am' Ca, K, kb' f, Ve , and V p are the measured amount of material in the tissue, blood concentration, overall steady-state uptake rate constant (slope of the lin ear portion of the graphical plot), rate constant of loss from the tissue, fraction of the amount in the reversible compartment(s) that returns into the blood, steady-state volume of the reversible compartment(s), and tissue blood volume, respectively (Patlak and Blasberg, 1985) . We have applied this analysis to R-IQNB uptake and binding in brain regions that are rich in muscarinic recep tors . The parameters determined by graphical analysis are related to the rate constants of the compartmental models (Fig. 1) by where Ke q is the equilibrium constant for rapidly revers ible nonspecific binding and k2/(k2 + k3) is the fraction (f) of "free" or unbound R-IQNB that leaves the brain. As suming that a second brain region is devoid of muscarinic receptors (no high-affi nity binding of R-IQNB) and that the amount of radioligand in this second region (A:n) can be measured independently, where the slope (K +) is KI(Ve + V�) , the prime (') refers to measurements or values in the second region, and D' is a constant that was previously defined (Patlak and Blas berg, 1985) . Assuming K;lk� = K11k2' K� q = Ke q , JV e > > V P ' and V� > > V� for any specific compartmental model, then
J.t -kb(t-T) C ( )d
and (C7) where V� K/k2 . (1 + Ke q ). Accordingly,
where Vd
